Science and Research committee  Sure. Thank you, Ms. Diab. I'll say a few words about that. We work very closely with research institutions such as, for instance, Dalhousie University in Halifax and our partners at Genome Atlantic, which are funded by the provincial government in Nova Scotia, to build projects

Science and Research committee  Thanks. I think the life sciences strategy is crucial right now, just because of global competitiveness when it comes to attracting talent. It's no secret that COVID caught everybody a little flat-footed, and suddenly everybody was trying to ramp up everything from testing to t

Science and Research committee  Thank you for the question, Ms. Gladu. I think it starts really with a foundation and having a strong foundational ecosystem. That includes, certainly, strong support for education in the K-12 system, which I know is not the purview of this committee, including opportunities thr

Science and Research committee  Sure. I might actually ask my colleague, Pari Johnston, to step in here. Pari is our vice-president of policy and public affairs, and she's really been doing a lot of great work on talent and skills for us. Pari, maybe I'll ask you to take the floor.

Science and Research committee  Thank you, Madam Chair. Good evening, everyone. I'm joining you today from Ottawa on the unceded traditional land of the Algonquin Anishinabe people. It's a real pleasure to be back again at committee, along with my colleague Pari Johnston, to discuss this important topic. It's

Science and Research committee  Yes. I think from a Genome Canada perspective, we bake that into all of our projects. Because of the way we do research, there has to be a connection into real-world use, and that can include, say, both industry and policy-making.

Science and Research committee  On this question of fragmentation, if I can follow up, I would say it's a reality. I don't want to overstate the case. The community works really hard to stay aligned. I talk with Paul all the time, and obviously Volker at VIDO and Genome Canada have a lot of intersections. That'

Science and Research committee  I might ask Pari to weigh in on this too, because I know she thinks a lot about this. I will just say that when it comes to fragmentation there are two pieces. One is that at the level of the researchers we find actually that increasingly there's a real appetite for collaboratio

Science and Research committee  Like the others that you've spoken with—frankly, like everybody—we've pivoted during the pandemic. What was fascinating about the science and research ecosytem was that COVID provided a very clear, shared sense of purpose. It didn't matter if you were, like Dr. Gerdts, working on

Science and Research committee  First, it's really baked right into our delivery model. We are not a granting organization like the granting councils. We actually proactively build research projects. We do that through the genome centres we have across the country. We have six centres. They are really on the gr

Science and Research committee  Wonderful. Thank you, Madam Chair. Good evening. I'm happy to be joining you tonight from Ottawa on the unceded traditional land of the Anishinabe Algonquin people. Thank you for the invitation to participate in this historic study on the state of science in Canada. First, I'd

Finance committee  There are a few different pieces. Very early on, Genome Canada participated in a coordinated response that involved a variety of federal research organizations. It was led by the Canadian Institutes of Health Research. In that competition, we funded a project at the University o

Finance committee  Thank you very much, Mr. Chair. I am very pleased to be here today on behalf of Genome Canada. I'm joined by Pari Johnston, who is our vice-president of policy and public affairs. Today I'm going to talk to you about genomics, which is the branch of science that looks at the mo

Health committee  Certainly I'll say from Genome Canada's perspective that the researchers as individuals are used to collaborating internationally. What we're seeing now is a more systematic approach to this and we're having a lot of international tools. For instance, there is something called th

Health committee  Thank you so much for the question. Again, I'm going to pass to Dr. Bell, my colleague, who may be more familiar with those types of questions, especially with regard to SARS.